Home

Duplicate Month shutter nejm table 1 Full ribbon renewable resource

Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest | NEJM
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest | NEJM

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma  | NEJM
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma | NEJM

Tirzepatide Once Weekly for the Treatment of Obesity | NEJM
Tirzepatide Once Weekly for the Treatment of Obesity | NEJM

Statins and the Risk of Colorectal Cancer | NEJM
Statins and the Risk of Colorectal Cancer | NEJM

Hospitalization and Mortality among Black Patients and White Patients with  Covid-19 | NEJM
Hospitalization and Mortality among Black Patients and White Patients with Covid-19 | NEJM

Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with  Diabetes | NEJM
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes | NEJM

Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China |  NEJM
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China | NEJM

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma |  NEJM
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma | NEJM

A Communication Strategy and Brochure for Relatives of Patients Dying in  the ICU | NEJM
A Communication Strategy and Brochure for Relatives of Patients Dying in the ICU | NEJM

Outcomes of Daytime Procedures Performed by Attending Surgeons after Night  Work | NEJM
Outcomes of Daytime Procedures Performed by Attending Surgeons after Night Work | NEJM

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity  | NEJM
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity | NEJM

Saw Palmetto for Benign Prostatic Hyperplasia | NEJM
Saw Palmetto for Benign Prostatic Hyperplasia | NEJM

Health Care Hotspotting — A Randomized, Controlled Trial | NEJM
Health Care Hotspotting — A Randomized, Controlled Trial | NEJM

Clinical Characteristics of Covid-19 in New York City | NEJM
Clinical Characteristics of Covid-19 in New York City | NEJM

Five-Year Outcomes with PCI Guided by Fractional Flow Reserve | NEJM
Five-Year Outcomes with PCI Guided by Fractional Flow Reserve | NEJM

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas | NEJM
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas | NEJM

Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated  Nursing Home Residents | NEJM
Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents | NEJM

Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine | NEJM
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine | NEJM

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell  Transplantation | NEJM
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation | NEJM

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 | NEJM
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 | NEJM

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes  | NEJM
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes | NEJM

Remdesivir for the Treatment of Covid-19 — Final Report | NEJM
Remdesivir for the Treatment of Covid-19 — Final Report | NEJM

The ClinicalTrials.gov Results Database — Update and Key Issues | NEJM
The ClinicalTrials.gov Results Database — Update and Key Issues | NEJM